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Dr Frank Hanley (Stanford, Calif). Dr Vida and his colleagues
have addressed an important issue, that is, maximizing mainte-
nance of pulmonary valve annular integrity during tetralogy of
Fallot repair. There is a long history focusing on maintenance of
pulmonary valve annular integrity in tetralogy of Fallot dating
back to the early work of John Kirklin, who primarily focused
on Z scores alone.
Over the years many technical maneuvers have been suggested
to improve the percentage of patients in whom the annulus is
preserved. In recent years, the introduction of intraoperative
balloon dilation of the annulus has been introduced as one of these
options, somewhat parallel to Hegar dilation or other forms of
dilation of the valve. Several publications since 2007 have
retrospectively assessed the potential benefit of this technique.
This study by Dr Vida and his colleagues is the first to
incorporate at least some degree of prospective design. The
authors prospectively assigned cohorts of patients either to receive
or not to receive an intraoperative balloon procedure versus the
standard treatment. And they used a predefined anatomic
characteristic, the size of the pulmonary annulus preoperatively,
to determine which group the patients would belong.
The results are encouraging that this may be a useful technique
and the study is an important contribution. There are, however,
uncertainties and significant limitations with respect to drawing
definitive conclusions based on the results. I have a few questions
that address those potential limitations.
The first relates to study design. It seems unfortunate that you
did not match the patients based on their pulmonary valve annular
size. So as it turns out, you have picked a favorable anatomic group
who get the preservation and a more unfavorable anatomic group
that received the standard technique, so you can see where a
potential bias would be present in the long-term results. Why
did you not decide to do a matched control of the pulmonary valve
annular size and just randomize matched patients into those
2 groups? It would have been easy to do.
Dr Vida. We started to apply this technique a few years ago.
At the beginning, we decided to start with milder forms of
tetralogy of Fallot with less severe pulmonary valve Z scores. As
we have gained more experience with this new technique, we
have been treating even more severe forms of tetralogy of Fallot.
Our initial limit for choosing the balloon dilation technique was
a pulmonary valve Z score equal to or more than 3, and this, at
the beginning, was surgeon dependent. In the last couple of years,
with the advent of more aggressive additional pulmonary valve
plasty techniques, such as leaflet delamination, we decided to be
more aggressive, applying this technique in patients with a Z score
as low as 4.
Initially, we had a tendency to oversize our balloon catheters
during the pulmonary valve dilation phase, based on theery c February 2014
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Dexperience from the catheter laboratory, where our cardiologist
colleagues usually go up to 120% to 150% of the initial pulmonary
valve diameter. However, we have learned that, to avoid
unexpected tears of the pulmonary valve leaflet or annulus during
the dilation, it is better to dilate the annulus up to the expected
normal value for the patient’s body surface area by using
high-pressure noncompliant balloons.
As you pointed out, 1 of the major limitations of this study is
that it is not a prospective randomized clinical trial. We analyzed
our patient population in a retrospective fashion, comparing
patients who underwent pulmonary valve preservation with
patients who underwent a standard transatrial/transpulmonary
repair technique.
Looking back at our results, we were able to preserve almost
half of the pulmonary valves in our patients with tetralogy of
Fallot. However, we can speculate, considering the latest
achievements with this technique, that we could have saved
more valves during the early stages of our experience, potentially
saving the pulmonary valve in up to the 75% of our patients.
Dr Hanley. So I mean clearly this was more learn-as-you-go
than prospectively designing. The read of the paper, in all fairness,
sounds a little bit more like it was prospectively set up that way.
But we have all been there, and learning as we go is a good
technique, I am not criticizing that at all.
Another question relates to the follow-up. There is a
discrepancy in the median follow-up periods for the 2 groups,
and it is large: 433 days for the balloon group and 712 for the other
group. And importantly, over the 433 days of follow-up for the
preservation group, the percentage of patients who developed
significant regurgitation almost doubled from 11.8% to 20%.
A skeptic I guess could argue that if the preservation group was
allowed to go out to 712 days, almost another 300 days, if there
was another point on the curve, there was probably going to be a
significant increase further, because it has already been
demonstrated there has been some, a further increase in the
amount of regurgitation, and would it be different than the control
group?
Dr Vida. Yes, the follow-up time is different between out study
groups. In fact, as we became more familiar with the pulmonary
valve preservation technique, we were able to preserve most
pulmonary valves during early repair of tetralogy of Fallot,
especially in the last few years; this contributed to the shorter
follow-up time in the preservation group.
Nonetheless, the shorter postoperative follow-up time, and
because we are still in a learning phase with this new technique,
our results are encouraging. In fact, most patients in the
preservation group, almost 90%, were discharged home with
none to trivial pulmonary valve regurgitation. Only a few of
them, all with severe forms of tetralogy of Fallot, had a moderate
degree of pulmonary valve regurgitation.
On the contrary, when we used an artificial cusp to achieve
pulmonary valve competence during transannular patch repair,
we have since the beginning had a higher frequency of more severe
forms of valve regurgitation, which progressed over time in most
patients.
Dr Hanley. Absolutely. You have clearly shown that short term
you come up with less regurgitation. I guess the concern is way
further out.The Journal of Thoracic and CaOne last brief question. For what percentage of the patients in
the preservation group did you use artificial material on the patch?
Because I would say, and I will not respond after, but my concern
there is the more you use artificial material on a young infant,
pulmonary valve or any valve, the more likely you are going to
have failure later.
Dr Vida. We needed to use biological material in 4 patients
during pulmonary valve preservation. All these patients had
more severe forms of tetralogy of Fallot, with an initial Z score
less than 3.5. These patches were used to further extend the
pulmonary valve leaflet coaptation area after balloon dilation
and leaflet delamination, in order to achieve optimal valve
competence.
Dr Christopher A. Caldarone (Toronto, Ontario, Canada).
You bring up a novel concept, this concept of the delamination
to extend the size of the pulmonary valve leaflets, and I think
that would warrant some more discussion in terms of what the
limits are to that technique and there may be a few tips that you
may have in that regard. Can you just give us the briefest of
comments on that.
Dr Vida. The pulmonary valve in patients with tetralogy of
Fallot is usually thick and dysplastic and in most cases bicuspid.
Following balloon dilation, a gap in the valvular tissue is usually
present at 1 commissure level. In order to fill this gap and to
make that valve competent, we extend the pulmonary leaflets by
delaminating them at the hinge point level down to the right
ventricular myocardium.
After delamination, a good coaptation between leaflets is
usually achieved, however leaflets are usually prolapsing and
need to be resuspended recreating a new commissure. If the
leaflet is too short after delamination, the risk is a decrease in
its motion after resuspension. To avoid the creation of a still,
immobile leaflet, we decided to extend 1 leaflet end by means
of a prosthetic patch. An initial concern deriving from the
delamination process was possible right ventricular muscle
blood infiltration. However, it did not happen in our patients,
possibly because the delaminated site is exposed to the pressure
of the pulmonary district, which is usually low in patients with
tetralogy of Fallot.
Dr Caldarone. It is very interesting.
Dr Emile Bacha (New York, NY). Nicework. As you know, I am
a proponent of the technique, but I have given it up for the severe
end of the spectrum of tetralogy of Fallot. I do not use it anymore
for very low Z scores or severely stenotic valves. I use it for
the moderate range of Z scores up to 2.5, 3. I do not really
like to use Z score either because it does not take into account
the morphology of the pulmonary valve, and only measures
the annular size with no accounting for the effective orifice and
the cusp morphology.
However, it seems to me what you are doing is using a balloon
as only 1 of the steps in your management of your severe tetralogy
of Fallot spectrum. You are using patches, you are putting stitches
in the valve. And so I would agree with Dr Hanley’s comment that
probably what you are going to see long term is more pulmonary
regurgitation developing because you have instrumented this valve
so much by necessity. And in my view, I would rather do a
controlled surgical intervention on a severely stenotic valve,
such as dividing it where I want to, as opposed to having a balloonrdiovascular Surgery c Volume 147, Number 2 695
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Dwith a somewhat nondiscriminate tear of the valve, and then
reconstruct this valve.
Dr Vida.Well, I agree with you. This treatment is appealing for
milder forms of tetralogy of Fallot with a pulmonary valve Z score
of 3 or higher. With the advent of a more aggressive approach,
we were able to treat more severe forms, and, so far, have achieved
good mid-term results. These results are significantly superior to
the results from our standard transatrial/transpulmonary approach.
However, a longer follow-up is certainly mandatory to prove the
efficacy of this technique.
Dr Bacha. I do not disagree with plasty for the valve and
working on the valve trying to preserve it. But I am saying that,696 The Journal of Thoracic and Cardiovascular Surgat the severe end of the spectrum, you probably have more control
over what you do with this valve if you divide it where you want it,
as opposed to introducing a balloon. The valve may tear in a place
that you do not want it to tear.
Dr Vida. Because of its high success rate, our current policy is
to attempt the preservation of the pulmonary valve in every single
patient during repair of tetralogy of Fallot. This technique
guarantees superior results in terms of pulmonary valve
competence at discharge compared with our standard repair. In
cases where the pulmonary valve cannot be preserved, these
patients can be easily converted to the standard approach without
additional risk.ery c February 2014
